AllianceRx Walgreens Prime to Distribute Probuphine Implants
Restricted implants indicated for maintenance of opioid dependency.
FDA Foreshadows Stronger Opioid Enforcements and New R&D Guidelines
Increasing death tolls have prompted significant initiatives from governmental agencies.
Opinion: Hard Work is Inevitable, but Burnout is Not
Note the physiological signs of stress and consider necessary changes.
Walgreens Tests Pharmacy-Only Stores
As drug dispensing continues to drive revenue, pharmacies look to shed retail.
Increased Risk of Blood Clots and Death Seen with Higher Dose Tofacitinib
Higher-dose tofacitinib linked to greater risk of pulmonary embolism in RA patients.
Opinion: Pharmacists Are Best Suited to Improve Adherence
Learning a patient's specific situation might help overcome adherence barriers.
PPSI Honors Distinguished Person of the Year
State Senator Jeff Stone tackles PBM reform, reimbursement rates.
Avoiding Pharmacist Burnout
Professional associations, gratitude can keep you engaged, healthy
Lower Drug Prices Aren’t Worth Higher Health Risks
How HHS efforts to increase competition could hurt patients.
How to Prevent Medication Errors
Pharmacists must cultivate a culture of safety, training to protect patients.
New Drug Review: Dsuvia (Sufentanil) for Acute Refractory Pain
Sublingual form approved for short-term use.
Medtronic plc Granted Breakthrough Device Clearance for PCL Insulin Pump
The new device will increase real-time personalization and predictive diagnostics for patients.
Better Management Strategies Needed, Suggests Ninth Annual Medical Pharmacy Trend
The report by Magellan Rx Management indicates PMPM, site of service, and Medicaid prices continue to increase.
Tax Cuts and Jobs Act of 2017 Affecting Pharmacy Accounting
Pharmacies now may switch from accrual to cash accounting.
Cablivi for Acquired Thrombotic Thrombocytopenic purpura
What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.
Jeuveau (PrabotulinumtoxinA-xvfs) for Glabellar Lines
What you need to know about the new botulinum toxin product.
Study: DOACs Equal to or Better Than Warfarin
DOACs are as good as warfarin in preventing atrial fibrillation complications.
New Guidelines: NOACs Preferred Over Warfarin in AFib
Three cardiology groups now recommend using NOACs over warfarin in atrial fibrillation.
Generic Tolterodine Tartrate ER Capsules for Overactive Bladder
Opinion: Avoiding "White Coat Marketing" Accusations
Using healthcare professionals to market products is not illegal, but has gained considerable scrutiny from authorities.
Small Doses: February eNews Roundup
2018 U.S. drug prices, OTC/coprescribing increasing access to Naloxone, standardized opioid prescribing in children, and more.
Opinion: Responding to the Rise of E-Cigarettes
E-cigarettes have reinvented tobacco consumption and reemphasized smoking's consequences.
Most Profitable Pharmacy Services to Offer
Consider these services to improve your independent community pharmacy's return on investment.
Talzenna for gBRCAm HER2-negative Locally Advanced or Metastatic Breast Cancer
5 Tips for Getting Started with Niche Services
Advice from pharmacists whom have adopted new approaches in their practice.
Diversify and Prosper
How to build new revenue streams and show your value by expanding services.
Drugstore Chains, Pharmacy Groups Support CMS DIR Fee Rule
More than 150 pharmacy stakeholder organizations - including drug chains such as Walgreens - support a Centers for Medicare and Medicaid Services’ proposal that would eliminate direct and indirect remuneration (DIR) fees.
Video App for Directly Observed Therapy (DOT)
New app may improve directly observed therapy adherence for TB, opioid abuse treatment, and diabetes.
Independent Pharmacy Organization Names First-Ever CEO
Gerry Crocker talks with Drug Topics on his plans to grow the Association of Affiliated Pharmacies and Apothecaries (AAPArx).
Valsartan and Related Products See Drastic Price Increase
Alembic Pharmaceuticals and MacLeods Pharmaceuticals have drastically increased prices as competition in valsartan and related medications was hindered by 2018 recalls.
